Replies to post #10239 on GTC Biotherapeutics (fka GTCB)

[moustifouette]

At one hand, Atryn commercialization for HD occurred only at the very end of 2007. Low sales are probably expected in 2008.
On the other hand, Atryn still needs a lot of R&D to be approved in more indications, like DIC.